Integra Lifesciences Holdings Corp (NASDAQ:IART) currently has a daily average trading volume of 689.42K but it saw 429645 shares traded in last market. With a market cap of 1.22B USD, the company’s current market price of $15.83 came rising about 0.51 while comparing to the previous closing price of $15.75. In past 52 weeks, the stock remained buoying in the range of price level as high as $32.66 and as low as $15.51. In the recent trading on the day, stock has struck highest price mark of $15.455 while lowest mark touched by it was $15.955.
Taking a look at 20-day trading activity of Integra Lifesciences Holdings Corp (IART) gives us an average price of $19.67, while its current price level is -51.53% below from 52-week high level whereas it is 2.06% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $21.81 while that of 200 days or SMA-200 reads an average of $22.50. A closer look into the stock’s movement over the week reveals that its volatility is standing at 6.20% during that period while stretching the period over a month that decreases to 5.96%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 24.31 which implies that the stock is in oversold territory.
Over the week, IART’s stock price is moving -9.13% down while it is -30.63% when we observe its performance for the past one month. Year-to-date it is -30.20% down and over the past year, the stock is showing a downside performance of -50.25%.
The company is expected to be releasing its next quarterly report on 2025-Feb-24, for which analysts forecasted an EPS of 0.43 while estimate for next year EPS is 2.46. In next quarter, company is expected to be making quarterly sales of $417.04M as analysts are expecting the sales for current fiscal year at $1.68B and seeing the company making $1.75B in sales next year. Moreover, analysts are in estimates of $381.17M for current-quarter revenue.
Currently, Integra Lifesciences Holdings Corp’s total number of outstanding shares is 77.17M. Company’s return on investment (ROI) stands at -0.24% and return on equity (ROE) at -0.44%. It has a 5.82 of forward P/E ratio. Stock’s beta reads 1.34. Stock has a price to book (P/B) ratio of 0.79 while price to sale or P/S ratio amounts to 0.76. Its return on asset (ROA) is -0.18% on average.
